Cargando…
Angiotensin II type 1 receptor agonistic autoantibody blockade improves postpartum hypertension and cardiac mitochondrial function in rat model of preeclampsia
Women with preeclampsia (PE) have a greater risk of developing hypertension, cardiovascular disease (CVD), and renal disease later in life. Angiotensin II type I receptor agonistic autoantibodies (AT1-AAs) are elevated in women with PE during pregnancy and up to 2-year postpartum (PP), and in the re...
Autores principales: | Booz, George W., Kennedy, Daniel, Bowling, Michael, Robinson, Taprieka, Azubuike, Daniel, Fisher, Brandon, Brooks, Karen, Chinthakuntla, Pooja, Hoang, Ngoc H., Hosler, Jonathan P., Cunningham, Mark W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8562001/ https://www.ncbi.nlm.nih.gov/pubmed/34727994 http://dx.doi.org/10.1186/s13293-021-00396-x |
Ejemplares similares
-
Empagliflozin Ameliorates Preeclampsia and Reduces Postpartum Susceptibility to Adriamycin in a Mouse Model Induced by Angiotensin Receptor Agonistic Autoantibodies
por: Zhai, Ruonan, et al.
Publicado: (2022) -
The detrimental role of angiotensin receptor agonistic autoantibodies in intrauterine growth restriction seen in preeclampsia
por: Irani, Roxanna A., et al.
Publicado: (2009) -
Role of agonistic autoantibodies against type-1 angiotensin II receptor in the pathogenesis of retinopathy in preeclampsia
por: Liu, Fang, et al.
Publicado: (2016) -
Association of Angiotensin Receptor Autoantibodies With Cardiovascular Abnormalities in Preeclampsia
por: Minhas, Anum S., et al.
Publicado: (2021) -
Elevated Transglutaminase Activity Triggers Angiotensin Receptor Activating Autoantibody Production and Pathophysiology of Preeclampsia
por: Liu, Chen, et al.
Publicado: (2015)